@kaydaustin I totally agree. I am a cancer survivor and have always let my employers know. It’s honest and a part of who I am. Congrats on your new role!!
mAb treatment gives you expensive, temporary, synthetic antibodies AFTER you are exposed or infected with COVID.
The vaccine gives you inexpensive, durable, natural antibodies BEFORE you are exposed or infected with COVID.
This is crazy!
This is a brilliant visualization of how, as vaccinations increase, COVID hospitalizations will decrease dramatically--and the vaccinated will necessarily become a larger and larger % of the hospitalizations.
Math.
@chasedave@chasedave Totally agree. It is also becoming more and more apparent that this is not isolated to a certain age group either. Protecting social and emotional well-being is more than half the battle
You may have missed a lot of good news about another vaccine today
✓ No CVST or thrombotic events, > 64.5 million doses
✓ 95% protection vs severe infections in extended 6 mo f/u of 900 cases in main trial
✓ Progress for vaccine vs B.1. 351, and kids
https://t.co/dvsAE8ItzY
This is our warning call, America.
Cases are now climbing again in a majority of states--esp across the northeast and midwest.
@CDCDirector Walensky is right to be sounding the alarm. This is how surges start.
55% of tech workers surveyed said they would quit their job if they are not able to work remotely after the pandemic is over. I think this number will be even higher. https://t.co/h00IbPfZYM
Understanding, contextualizing the risk of death from #COVID19
https://t.co/UrPn0BPkVm
@bmj_latest A provocative new analysis by @d_spiegel showing how there is a close match to "normal" age-related risk of all-cause death
In patients who had recovered from #COVID19, 87.4% reported persistence of at least 1 symptom, particularly #fatigue and #dyspnea https://t.co/LHceshfSQa
As schools open and kids begin to venture outside then back into a multigenerational home, are we worsening an already prevalent #racialdisparity gap for #COVID19 transmission?
This #COVID19 church service outbreak in 91 people (graph via @GovMikeDewine) is very instructive.
Kids ranging from 6-16 years old are in the chain of transmission to other kids and adults.
What I believe will be the BEST NEWS: the first very cheap, highly replicable saliva test is about to be approved by the @US_FDA.
It costs $2-3 per sample!
It uses interchangeable reagents for scale
It new capacity
More on this soon
Kudos @YaleMed@NBA@robbysikka